Metastatic Lymph Node 64 (MLN64) Expression in Gastric Cancer: The Clinical and Molecular Implications in Drug Resistance

AMBER XINYU LI; JIMMY JIANYUAN ZENG; ELYAS KHAN; Q. PING DOU; XINGUO ZHUANG; EDISON KE JI; FIONA RUGE; TRACEY A. MARTIN; SHUQIN JIA; WEN G. JIANG

doi:10.21873/cgp.20427

Article Information

vol. 21 no. 1 30-40

DOI

https://doi.org/10.21873/cgp.20427

PMID

38151289

Published By

International Institute of Anticancer Research

Print ISSN

1109-6535

Online ISSN

1790-6245

History

Received August 30, 2023
Revision received October 10, 2023
Accepted October 11, 2023
Published online December 27, 2023.

Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

AMBER XINYU LI¹,
JIMMY JIANYUAN ZENG¹,
ELYAS KHAN²,
Q. PING DOU¹,²,
XINGUO ZHUANG¹,
EDISON KE JI³,
FIONA RUGE¹,
TRACEY A. MARTIN¹,
SHUQIN JIA³ and
WEN G. JIANG¹ ⇑

¹Cardiff University School of Medicine, Cardiff, U.K.;
²Karmanos Cancer Institute, Department of Oncology, School of Medicine, Wayne State University, Detroit, MI, U.S.A.;
³Gastrointestinal Cancer Centre, Peking University Cancer Hospital, Beijing, P.R. China

Correspondence to: Professor Wen G. Jiang, Cardiff China Medical Research Collaborative (CCMRC), Division of Cancer and Genetics (DCG), Cardiff University School of Medicine, Henry Wellcome Building, Heath Park, CF14 4XN Cardiff, U.K. Tel: +44 2920687065, e-mail: jiangw{at}cardiff.ac.uk

View Full Text